We have previously reported that low doses of melatonin inhibit apoptosis in both dexamethasone-treated cultured thymocytes (standard model for the study of apoptosis) and the intact thymus. Here we elucidate the mechanism by which this agent protects thymocytes from cell death induced by glucocorticoids. Our results demonstrate an effect of melatonin on the mRNA for antioxidant enzymes in thymocytes, also showing an unexpected regulation by dexamethasone of these mRNA. Both an effect of melatonin on the general machinery of apoptosis and a possible regulation of the expression of the cell death related genes bcl-2 and p53 are shown not to be involved. We found melatonin to down-regulate the mRNA for the glucocorticoid receptor in thymocytes (glucocorticoids up-regulate their own receptor). The decrease by melatonin of mRNA levels for this receptor in IM-9 cells (where glucocorticoids down-regulate it) demonstrates that melatonin actually down-regulates glucocorticoid receptor. These findings allow us to propose the effects of melatonin on this receptor as the likely mediator of its thymocyte protection against dexamethasone-induced cell death. This effect of melatonin, given the oxidant properties of glucocorticoids, adds another mechanism to explain its antioxidant effects.-Sainz, R. M., Mayo, J. C., Reiter, R. J., Antolín, I., Esteban, M. M., Rodríguez, C. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J. 13, 1547-1556 (1999) 
Melatonin is a chemical mediator produced mainly in the pineal gland, although other organs have been demonstrated to have the enzymatic machinery for its synthesis. The classical effects of melatonin relate to the control of the circadian rhythms and regulation of the hypothalamo-pituitary-gonadal axis, but other actions have also been reported (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . The most recently described properties of melatonin are 1) its antioxidant capability, acting both as a free radical scavenger (11, 12) and a stimulator of activity (13, 14) and mRNA levels for several antioxidant enzymes (8, 15, 16) and 2) its antiapoptotic effects in thymocytes (17, 18) and neuronal cells (16, 19, 20) . The antioxidant and antiapoptotic properties suggest possible clinical applications of this mediator particularly in the prevention of free radical damage and apoptosis in neurodegenerative diseases (21) (22) (23) .
Most T cells synthesize their receptors once they are in the thymus. Thymocytes may thereafter proceed in one of the following ways: they may 1) be selected positively and then mature in the thymic medulla, where they are insensitive to apoptosisinducing factors, 2) be selected negatively and die in a typical programmed cell death process (24) , or 3) remain unselected in the thymic cortex (the vast majority of them) extremely sensitive to multiple apoptosis-inducing factors (e.g., oxidative stress, DNA damaging agents, radiation, and especially glucocorticoids) (24) . Concentrations of glucocorticoids in a high physiological range readily induce apoptosis in nonselected thymocytes. Cohen et al. (24) proposed that these hormones are also responsible for the physiological apoptosis occurring in thymus with aging. The rise in thymus weight by adrenalectomy seems to support this (25) . It is because of these observations that the induction of apoptosis by dexamethasone in thymocytes from the thymic cortex is a standard in vitro model for the study of apoptosis.
Here we investigated the mechanism by which melatonin inhibits cell death induced by dexamethasone in thymocytes. To do this, we analyzed the effect of this hormone on cell death induced by other agents, examining its influence on the expression of several genes related to programmed cell death. We conclude that regulation of the expression of the glucocorticoid receptor (GcR) 2 gene could be the main mediator of the antiapoptotic effect of melatonin in the thymus.
MATERIALS AND METHODS

Animals
Wistar rats were maintained under controlled temperature (20Ϯ2°C) in the animal room facilities. Food and water were available ad libitum and photoperiodic conditions were constant (12:12 photoperiod, lights on at 07:00). Animals were killed by decapitation.
Cell culture
After decapitation thymus was quickly removed and immersed in Hanks' balanced salt solution (HBSS) containing glucose (1 g/l) to preserve cellular viability. Thymocytes were obtained by pressing the thymus against a sterile stainless steel screen. After several washes with HBSS and recovery of the cells by centrifugation at 1000 rpm for 5 min, cells were filtered through a smaller screen. Thymocytes were maintained in RPMI 1640 culture medium supplemented with 10% fetal bovine serum (FBS), sodium bicarbonate (2 g/l), and 1% antibiotic-antimitotic mixture (100 g/ml penicillin, 100 g/ml streptomycin, and 25 g/ml amphotericin) at 37°C and 5% CO 2 . Cells were counted with a NEUBAUER camera and cultured in plastic plates (NUNC, Roskilde, Denmark).
IM-9 cells were cultured in RPMI 1640 culture medium supplemented with 10% FBS. Cells were grown in suspension in T-75 flasks at 37°C and 5% CO 2 .
DNA electrophoresis
Cells were cultured in 35 mm plates at a density of 3 ϫ 10 6 cells/ml and collected by centrifugation after scraping the plates. They were homogenized in 1 ml of homogenization buffer (0.1 M NaCl, 0.01 M EDTA pH 8, 0.3 M Tris-HCl pH 8, and 0.2 M sucrose) and processed as described Tilly et al. (26) . To analyze DNA fragmentation, 15 g of DNA were electrophoresed in 2% agarose gel in TAE buffer (2%) and 0.5 g of ethidium bromide. Gel was run at 5 v/cm, visualized under UV, and photographed with a POLAROID camera.
Quantification of DNA fragmentation
Cells were collected and recovered in Eppendorf tubes by centrifugation at 13,000 ϫ g for 2 min. The pellet was washed in phosphate-buffered saline (PBS) and cells were lysed with 400 l of a lysis buffer (10 mM Tris pH 7.5, 1 mM EDTA, and 0.2% of Triton X-100) by incubation in ice water for 20 min. High and low molecular weight DNAs were obtained as described by Collota et al. (27) and quantified following a colorimetric assay described by Burton (28) . Absorbance was measured at 600 nm in a spectrophotometer and percentage of fragmentation was calculated as follows:
% fragmentation ϭ supernatant ODr 600 /supernatant ODr 600 ϩ pellet ODr 600
Morphometric analysis
Cells cultured at a density of 3 ϫ 10 6 cells/ml were collected and recovered by centrifugation at 1000 ϫ g for 5 min. They were washed several times in PBS and fixed in 500 l of 3% glutaraldehyde in 0.1 M phosphate buffer, pH 7.3, for 2 h at 4°C. Fixed cells were then embedded in a small volume of 1% agar, dehydrated in increasing concentrations of acetone, and embedded in SPURR resin (EMS, Fort Washington, Pa.). Semithin (1 M) sections were obtained at four different levels separated by 30 M from three blocks of each experimental group and stained with 0.2% toluidine blue. Apoptotic and nonapoptotic cells were counted in 15-20 areas in each section at 100ϫ. A minimum of 500 cells was counted in each group. The percentage of apoptotic cells was calculated in relation to the total number of cells.
RNA isolation and Northern blot analysis
Thymus tissue (400 mg) or cells cultured in 100 mm plates at a density of 50 ϫ 10 6 cells/plate were used. Total RNA was extracted according to the method described by Chomczynski and Sacchi (29) . (poly(A) ϩ -RNA was obtained from total RNA with a purification mRNA kit (Pharmacia Biotech, Piscataway, N.J.). After electrophoresis in a 1% agarose gel, RNA was transferred to a nylon membrane (HYBON-N ϩ , Amersham Life Sciences, Little Chalfont, U.K.) and hybridized with the following probes: a 1.6 kb HindIII/ECO RI fragment from the rat catalase cDNA clone pTZCTL (30); a 0.6 kb EcoRI fragment from the rat copper-zinc superoxide dismutase (Cu-Zn SOD) cDNA clone, pUC13 (31); a 0.8 kb SalI fragment from the rat glutathione peroxidase (GPx) cDNA clone, LK 440 (32); a 2.4 kb BamHI fragment from the GcR cDNA clone pSP65 (33); a 0.85 kb ECO RI/HindIII fragment from the human bcl-2 cDNA clone pBluescript (34); a 2 kb BamHI fragment from the mouse p53 cDNA clone pBR322 (35) ; and a 2.1 kb fragment from the human ␤-actin cDNA clone, pHFBA-1 (36), which was used to normalize the remainder of the mRNA values. Autoradiographies shown belong to a representative experiment.
Statistical analysis
Data result from three independent experiments. Results are shown as the mean Ϯ standard error. Statistic analysis was performed with analysis of variance, followed by a Student Newman-Keuls test.
RESULTS
Melatonin effects on mRNA levels for antioxidant enzymes
Glucocorticoids (GC) have recently been found to enhance oxidative stress-induced cell death (37); this is prevented by melatonin in other systems by increasing the levels of mRNA for antioxidant enzymes (15, 16) . To determine whether the antiapoptotic action of melatonin in dexamethasonetreated thymocytes (17) correlates with the increase of antioxidant enzymes, we measured the levels of mRNAs for GPx, Cu-Zn SOD, and catalase in these cells.
Three groups of cells were used: one group received no treatment; a second group was treated with 10 Ϫ7 M dexamethasone; and a third group was treated with 10 Ϫ7 M dexamethasone plus 10 Ϫ7 M melatonin (preincubation of 3 h and coincubation with the dexamethasone for 6 additional hours). Both morphometric analysis of apoptotic cells and DNA electrophoresis confirmed that melatonin prevented cell death induced by dexamethasone (data not shown). Dexamethasone decreased the levels of mRNA for GPx (almost 40%) and increased the levels of mRNA for Cu-Zn SOD (45%) whereas melatonin prevented both of these changes (Fig. 1A,  B) . No mRNA for catalase was detected.
Melatonin did not prevent apoptosis induced by etoposide
To test whether melatonin was acting on the general machinery of apoptosis, programmed cell death was induced in the same experimental model, with etoposide causing apoptosis by inhibiting DNA topoisomerase II (38) .
Morphometric analysis, quantification of DNA fragmentation, and DNA electrophoresis gel pattern showed no differences between the group of cells treated with 50 M etoposide for 4 h and cells also treated with 10 Ϫ7 or 10 Ϫ9 M melatonin (preincubation of 3 h and coincubation with etoposide for an additional 4 h) ( Table 1 and Fig. 2A ). When cells were treated with 10 M etoposide for 18 h with or without administration of melatonin (3 h pretreatment and coincubation for an additional 18 h), the same results were obtained ( Table 2 and Fig. 2B ).
Melatonin increases mRNA levels for bcl-2 in thymus in vivo but does not affect these levels in cultured thymocytes
A nuclear receptor for melatonin has been reported (39) ; this receptor may be involved in the regulation of several mRNAs (9, 40) . To test whether melatonin was regulating the expression of the apoptosis-involved genes bcl-2 and p53, Northern analysis with the cDNA of these two genes was performed in both in vivo and in vitro experiments. Four groups of animals (nϭ8) were used for the in vivo experiment. The first group, killed at 25 days of age, was used as a control (young controls). The second group was intraperitoneally injected daily with 50 g/kg melatonin from 25 to 65 days of age. The third group was injected daily with a high dose of melatonin (500 g/kg). The vehicle alone was administered to a last group (old controls), also for 40 days.
mRNA for Bcl-2 decreased with aging and both doses of melatonin prevented this decrease. mRNA for p53 also decreased with age, but melatonin did not prevent this fall (Fig. 3A, B) .
Three groups of cells were used for the in vitro experiment: one group was left untreated; a second group was treated with 10 Ϫ7 M dexamethasone; and the last group was treated with 10 Ϫ7 M dexamethasone plus 10 Ϫ7 M melatonin. The mRNA for Bcl-2 did not change either after dexamethasone or dexamethasone plus melatonin treatment (Fig. 3C, D) .
Melatonin decreases the levels of mRNA for GcR
Given 1) that the only positive result in the antiapoptotic effect of melatonin in thymocytes was obtained when apoptosis was induced by dexamethasone; 2) the glucocorticoid-opposite effects of melatonin in the mRNA levels for antioxidant enzymes; and 3) the classically described steroid-related effects of melatonin, we surmised that melatonin may be regulating the GcR in this system. Northern analysis with the cDNA for GcR was performed in both in vivo and in vitro experiments.
The experimental designs were identical to those described above. The levels of mRNA for GcR in vivo increased with age (GcRI, 20%; GcRII, 30%), as expected, since GC are known to up-regulate their own receptor in T lymphocytes and melatonin prevented this increase (Fig. 4A, B) . In the in vitro experiment, dexamethasone increased the levels of GcR mRNA (GcRI, 45%, and GcRII, 35%) and melatonin prevented this rise (Fig. 4C, D) . 
Melatonin has a direct effect on GcR expression
As GC up-regulate their own receptor in thymus, the effects of melatonin seem to be opposite to the effects of these hormones both in terms of effects on the mRNA for antioxidant enzymes and on the mRNA for GcR. To determine whether melatonin reduces the action of GC in some way or is directly regulating its receptor expression, the effect of melatonin on the mRNA levels for GcR was studied in the IM-9 cells, where this receptor is down-regulated by its ligands (41).
As expected, dexamethasone decreased the levels of mRNA for GcR (GcRI, 35%; GcRII, 20%). Melatonin did not have the opposite effect of dexamethasone; on the contrary, the group treated with dexamethasone and melatonin showed mRNA levels for GcR below that of the group treated only with dexamethasone (GcRI, 70%; GcRII, 60% vs. control) (Fig. 5A, B) .
DISCUSSION
Thymocytic programmed cell death in vivo and in vitro has long been used as a model to study apopto- D) . Low (50 mg/kg) or high (500 mg/kg) melatonin doses were administered during 40 days to young rats (25 days) and the thymus was removed after death (65 days). For the in vitro experiment, 10 Ϫ7 M dexamethasone was (or was not: CON) added to the medium after preincubation with or without 10 Ϫ7 M melatonin for 3 h; cells were cultured with both agents during an additional 6 h. mRNA was obtained and Northern blot with the cDNAs for bcl-2 and ␤-actin was performed. The autoradiographic signal obtained is shown in panels A, C; the relative value obtained after normalization with the ␤-actin signal is represented in panels B, D, giving 100% to the values obtained in the thymus of 25 days control group or in the control group. a, b: P Ͻ 0.05 vs. all other bcl-2 groups; *P Ͻ 0.05 vs. all p53 groups. sis. We recently found that melatonin partially prevents apoptosis in thymocytes in vivo (physiological apoptosis with aging) or in vitro (dexamethasoneinduced) (17) . Glucocorticoids have been related to oxidative stress. Beaver and Waring (42) reported glutathione concentrations to decrease after dexamethasone administration, and Behl et al. (37) have shown that GC enhance oxidative stress-induced cell death in neurons. Because melatonin has important antioxidant properties (43) and its increase of mRNA for antioxidant enzymes has been proposed as its mechanism to prevent apoptosis in other systems (16), we studied the effect of melatonin on these mRNAs. The present findings suggest that, for this system, melatonin does not strictly regulate antioxidant enzymes mRNAs, but seems to exert an action opposite to that of GC.
Our finding on the decrease of GPx and increase of SOD by GC may well explain why these hormones enhance the oxidative damage induced by other substances, as a balance in the activity of these antioxidant enzymes is necessary to counteract cellular oxidative attack. Thus, the rise in SOD activity would increase intracellular levels of hydrogen peroxide (H 2 O 2 ) as consequence of the dismutation of the superoxide anion radical (O 2 -⅐ ). In the presence D) . Low (50 mg/kg) or high (500 mg/kg) melatonin doses were administered during 40 days to young rats (25 days) and the thymus was removed after death (65 days). For the in vitro experiment, 10 Ϫ7 M dexamethasone was added to the medium after preincubation with or without 10 Ϫ7 M melatonin during a period of 3 h and cells were cultured with both agents for an additional 6 h. A control group without treatment was also incubated. mRNA was obtained and Northern blot with cDNAs for GcR or ␤-actin was performed. A, C) Autoradiographic signal; B, D) Graph after normalization with the ␤-actin, where 100% was given to the mRNA levels of the GcR in the young control animals or in the control group. Levels of subunits GcRI and GcRII (6.5 and 4.5 kb) are shown. a: P Ͻ 0.05 vs. all other GcRI and GcRII groups; b: P Ͻ 0.05 vs. 25 and 65 days GcRI groups. *P Ͻ 0.05 vs. GcRI and GcRII in all groups.
of transition metals (most often Fe 2ϩ ) H 2 O 2 generates the highly toxic hydroxyl radical ( . OH), which has devastating actions within cells. When an increase in SOD activity occurs simultaneously with a reduced GPx activity (which converts H 2 O 2 into nontoxic products), the results can be disastrous in terms of free radical damage, consistent with the results of Peled-Kamar et al. (44) . These authors reported that the overexpression of Cu-Zn SOD in transgenic mice produces increased cell death in the thymus after administration of lipopolysaccharides, which show a rise in the production of H 2 O 2 and high levels of lipid peroxidation. The melatonin prevention of the imbalance in the mRNA for antioxidant enzymes caused by GC may be considered another facet of the antioxidant defenses of the organism.
Melatonin has also been shown to restore Zn 2ϩ levels in the thymus of old animals (45) and to antagonize the formation of the Ca 2ϩ -calmodulin complex (6) . It has been reported that DNA fragmentation, a hallmark of programmed cell death, is caused by a Ca 2ϩ -and Mg 2ϩ -dependent endonuclease that is inhibited by Zn 2ϩ (46) ; this enzyme could well be inactivated by melatonin. This does not seem to occur in the thymus, however. First, when morphometrical analysis of dexamethasone-induced apoptotic cells in thymocytes was performed, we found melatonin to prevent the morphological changes associated with programmed cell death. The fact that these markers precede and are independent from DNA fragmentation (47) -dependent endonuclease, it should do so regardless of the mechanism used to induce apoptosis; in the present study, melatonin was totally unable to prevent the fragmentation of DNA when it was induced by etoposide.
Bcl-2 and p53 are proto-oncogenes closely related to the process of programmed cell death (48, 49) . Bcl-2 protein has been reported to inhibit all processes of apoptosis in thymocytes except the deletion of the negatively selected thymocytes (50) . Melatonin has been reported to regulate the mRNA for several proteins (7, 8) possibly via a nuclear receptor (9, 40) . Although melatonin increased the levels of mRNA for Bcl-2 in vivo, this was not found in vitro, suggesting that the in vivo increase may have been an indirect consequence of melatonin administration rather than a direct effect on the expression of this oncogene. When animals are exposed to short photoperiods (rising melatonin levels), thymus weight also increases, mainly the medulla (51) . Given that bcl-2 mainly is expressed in the medulla (52), higher expression of this oncogene after chronic melatonin administration in vivo may have been a consequence of greater cellularity in this area. On other hand, since melatonin did not inhibit apoptosis induced by etoposide, it seems unlikely that bcl-2 mediated this effect, inasmuch as bcl-2 has been reported to inhibit apoptosis induced by dexamethasone, etoposide, radiation, or exposure to antibodies (53) .
Interleukin-2 (IL-2) and IL-4 mediate melatonin antiapoptotic effects in bone marrow stem cells (4) . These interleukins also inhibit apoptosis induced by dexamethasone in thymocytes where IL-2 increases Figure 5 . Effect of melatonin on mRNA levels for the GcR in IM-9 cells. Cells were preincubated with 10 Ϫ7 M melatonin for 3 h. Then 10 Ϫ7 M dexamethasone was added and cells were incubated with both agents for 6 additional hours. Another group without treatment was also incubated (CON). Northern blot was performed with the cDNAs for GcR and ␤-actin. A) Autoradiography of the Northern blot. B) Relative values after normalization with ␤-actin. 100% was given to the mRNA levels for GcR in control groups a, b: P Ͻ 0.05 vs. other GcRI and GcRII groups. mRNA for Bcl-2 (54). Although we did not measure interleukins, these are mitogenic factors in fetal and adult thymocytes (55), and we have found a decrease of cellular proliferation in thymus after melatonin administration (3). Nor did we find an accumulation of mRNA for Bcl-2 in thymocytes treated with melatonin. Bearing in mind that thymocytes only produce IL-2, we noted that our data do not support interleukins as mediators of the antiapoptotic effect of melatonin in thymocytes.
It seems that the effects of melatonin in the thymus are contrary to those of GC in terms of its effect on both GcR and antioxidant enzymes mRNA levels. These data suggest two possibilities: 1) melatonin may reduce the action of GC (by altering binding to the GcR, translocation of the GC-GcR complex into the nucleus, or binding of the GC-GcR complex to its response element in DNA); and 2) melatonin may regulate expression of the GcR itself. In the IM-9 cell line, GC down-regulate the expression of their receptor. The fact that melatonin magnifies the action of GC in this line, reducing the levels of mRNA for GcR, indicates that melatonin is not acting via any of the mechanisms mentioned in the first item. This suggests that melatonin regulates expression of the GcR gene (affecting transcription, translational efficiency, or mRNA stability), causing a reduction of the GcR and mediating through this decrease its antiapoptotic effects when apoptosis is induced by dexamethasone in thymocytes.
Melatonin has been reported to have a nuclear receptor (RZR-␣ and ␤/ROR-␣1, ␣2, and ␣3) that is an orphan of the nuclear receptor superfamily (39) . It has also been shown that this hormone binds purified cell nuclei from thymus (56) , suggesting the existence of its nuclear receptor in this tissue. Through this receptor, melatonin has been reported to regulate the expression of several genes (9, 40) . It is known that several nuclear receptors may bind to and activate each other's response elements, albeit with lower efficiency; they can also form heterodimers (57) . These and other characteristics make the study of the mechanisms of action of molecules having nuclear receptors quite complex. Melatonin is a highly soluble lipophilic molecule with a possible nuclear receptor, which makes it a candidate as a transcription factor similar to other steroids. Its receptor theoretically may be able to interact with other nuclear receptors or nuclear receptor response elements, making melatonin mechanisms of action complex and varied. This complexity may be enhanced by the fact that expression of Mel 1a melatonin receptor has been reported in T and B lymphocytes from rat thymus and spleen (58) , rendering it impossible to rule out a regulation throughout a phosphorylation cascade pathway. Hereby we demonstrate melatonin regulation of the GcR; however, a possible regulation of the melatonin receptor by GC and melatonin regulation of other steroid and nuclear receptors in general should be investigated further. 
